Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back

Core Insights - The company's new orders increased significantly by 49% in the third quarter compared to the same period last year [1] Group 1 - The substantial growth in new orders indicates strong demand for the company's products and services [1]